The impact of interferon plus ribavirin on response to therapy in black patients with chronic hepatitis C
Open Access
- 1 November 2000
- journal article
- clinical trial
- Published by Elsevier BV in Gastroenterology
- Vol. 119 (5), 1317-1323
- https://doi.org/10.1053/gast.2000.19289
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Cost effectiveness of interferon ?2b combined with ribavirin for the treatment of chronic hepatitis CHepatology, 1999
- Racial Differences in the Treatment of Early-Stage Lung CancerNew England Journal of Medicine, 1999
- The Prevalence of Hepatitis C Virus Infection in the United States, 1988 through 1994New England Journal of Medicine, 1999
- Chronic liver disease in central harlem: The role of alcohol and viral hepatitisHepatology, 1999
- Impaired health-related quality of life in chronic hepatitis C: The how, but not the whyHepatology, 1999
- Prediction of response during interferon alfa 2b therapy in chronic hepatitis C patients using viral and biochemical characteristics: A comparisonHepatology, 1997
- Therapy of hepatitis C: Cost-effectiveness analysisHepatology, 1997
- Why are African Americans under‐represented in medical research studies? Impediments to participationEthnicity & Health, 1997
- Typing of hepatitis C virus isolates and characterization of new subtypes using a line probe assayJournal of General Virology, 1993
- Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitisHepatology, 1981